ライフサイエンスコーパス: myoclonus

1 the VGKCC syndrome, had been misdiagnosed as myoclonus.

2 gressive encephalomyelitis with rigidity and myoclonus.

3 gressive encephalomyelitis with rigidity and myoclonus.

4 gressive encephalomyelitis with rigidity and myoclonus.

5 lear envelopes, alteration in locomotion, or myoclonus.

6 mice exhibit motor deficits and spontaneous myoclonus.

7 es not produce abnormal nuclear envelopes or myoclonus.

8 otentials indicated a cortical origin of the myoclonus.

9 t, slowly progressive, disabling, multifocal myoclonus.

10 xia, cortical sensory deficits, dystonia and myoclonus.

11 gressive encephalomyelitis with rigidity and myoclonus.

12 ellum is the underlying cause of posthypoxic myoclonus.

13 n of myoclonus in a rat model of posthypoxic myoclonus.

14 were evaluated in a rat model of posthypoxic myoclonus.

15 inds a precedent in the syndrome of cortical myoclonus.

16 d in an established rat model of posthypoxic myoclonus.

17 ain nuclei possibly involved in post-hypoxic myoclonus.

18 at underwent 4 min of cardiac arrest without myoclonus.

19 LF plays a contributing role in post-hypoxic myoclonus.

20 ma-hydroxybutyric acid for alcohol-sensitive myoclonus.

21 t may have contributed to the development of myoclonus.

22 oherence evident between signals in cortical myoclonus.

23 may be exaggerated in patients with cortical myoclonus.

24 nge of frequencies in patients with cortical myoclonus.

25 analyzed movement behavior in a patient with myoclonus.

26 e motor areas producing the typical regional myoclonus.

27 wever, with intact RRN and vMPJ never showed myoclonus.

28 ctivation of NMDA receptors in NMC can block myoclonus.

29 atients (1.2%) had isolated segmental spinal myoclonus.

30 of genetic progressive encephalopathies with myoclonus.

31 ism and dystonia with cognitive decline, and myoclonus.

32 excitability that eventually causes cortical myoclonus.

33 f 157 patients (62%) with available data had myoclonus.

34 dically refractory, progressive epilepsy and myoclonus.

35 ts were included, of whom 69 (16%) had early myoclonus.

36 gressive encephalomyelitis with rigidity and myoclonus.

37 tor cortex excitability, as seen in cortical myoclonus.

38 rapeutic hypothermia and 471 (18%) exhibited myoclonus.

39 limbic involvement), and two had opsoclonus-myoclonus.

40 gressive encephalomyelitis with rigidity and myoclonus.

41 ms were more common at younger age of onset (myoclonus 0.93, 0.90-0.97, p=0.0007; seizures 0.95, 0.92

42 ndromes (transverse myelitis (1), opsoclonus myoclonus (1)).

43 nt early, but quickly became overshadowed by myoclonus; 10 patients were wheelchair-bound by their la

44 onal neurological features; individuals with myoclonus (40 [47%] with PSEN1 mutations and 12 [33%] wi

45 ment disorders, including tremor (15 [94%]), myoclonus (5 [31%]), and parkinsonism (11 [69%]), were c

46 of 1-2 was reported in 9.8% of patients with myoclonus, 5.8% with MyS/SM, 5.7% with MSE, and 82.0% wi

47 verify that the lesions were responsible for myoclonus, 6 additional cats received N-methyl-D-asparta

48 (33 patients [77%] vs 41 patients [57%]) and myoclonus (8 patients [19%] vs 8 patients [4%]).

49 All cases initially presented with mild myoclonus affecting the upper limbs.

50 ine percent of cardiac arrest survivors with myoclonus after cardiac arrest had good functional outco

51 alongside, a trend towards worsening of the myoclonus after the cerebellar stimulation was observed.

52 edominantly distal, semi-continuous rhythmic myoclonus (all patients), generalized tonic-clonic seizu

53 tonomic disorders and spontaneous and evoked myoclonus, among other symptoms.

54 clude isolated and combined segmental spinal myoclonus and autoimmune episodic ataxia.

55 sive cortical dementia with pyramidal signs, myoclonus and cerebellar abnormalities that closely rese

56 by predominant alcohol responsive upper body myoclonus and dystonia.

57 Autosomal dominant cortical myoclonus and epilepsy (ADCME) is characterized by dista

58 this disorder as autosomal dominant cortical myoclonus and epilepsy (ADCME).

59 is characterized by distal, fairly rhythmic myoclonus and epilepsy with variable severity.

60 mental ability as well as the development of myoclonus and extrapyramidal signs are consistent manife

61 racetam is especially useful for posthypoxic myoclonus and gamma-hydroxybutyric acid for alcohol-sens

62 With myoclonus and good outcome, median ICU length of stay wa

63 is considered a rhythmic variant of cortical myoclonus and is part of the 'spectrum of cortical myocl

64 to exhibit periods of spontaneous or sensory myoclonus and locomotion beginning 24 h after decerebrat

65 l had cerebellar signs, and the majority had myoclonus and lower limb pyramidal signs, with relativel

66 beta3-deficient mice display frequent myoclonus and occasional epileptic seizures, documented

67 rx plus 7") pups display abnormal spasm-like myoclonus and other key EEG features, including multifoc

68 withdrawn in 330 of 427 patients (78%) with myoclonus and poor outcome, due to neurological futility

69 ge (median = 9.5), with progressively severe myoclonus and rare tonic-clonic seizures.

70 ane hyperexcitability and pathophysiology of myoclonus and related disorders.

71 18 and 15 (83%) of 18 patients had improved myoclonus and sedation after hydration versus eight (47%

72 resented as a progressive cognitive decline, myoclonus and seizures developing later in the disease,

73 Myoclonus and seizures were prominent features of this p

74 Myoclonus and seizures were the most common additional n

75 of abnormal neurotransmission, manifested by myoclonus and seizures, the molecular mechanisms by whic

76 was higher in the published data cohort for myoclonus and spasticity (19.4%, 16.6-22.2 and 15.0%, 12

77 ns in the DIAN-OBS cohort was low, including myoclonus and spasticity (9.3%, 95% CI 3.8-15.0), and se

78 c studies demonstrated a cortical origin for myoclonus and striking coactivation of agonist and antag

79 y-based diagnostic biomarkers for functional myoclonus and tremor.

80 s consists of: rapidly progressive dementia, myoclonus and typical electroencephalographic findings (

81 Other patterns were subcortical myoclonus and unclassifiable.

82 argic (lh) is characterized by ataxia, focal myoclonus, and absence epilepsy due to a loss-of-functio

83 association with paraneoplastic opsoclonus, myoclonus, and ataxia.

84 a bilateral jerky tremor, stimulus-sensitive myoclonus, and difficulty with tandem gait.

85 oplastic cerebellar degeneration, opsoclonus-myoclonus, and encephalitides affecting the limbic syste

86 display severe ataxia, tremulous movements, myoclonus, and hypersensitivity to ethanol.

87 gressive encephalomyelitis with rigidity and myoclonus, and less frequently in other variants of stif

88 There are no approved medications for myoclonus, and most therapies are borrowed from the anti

89 t pupillary or corneal reflexes, presence of myoclonus, and neuron-specific enolase greater than 75 m

90 Movement disorders, including tremor, myoclonus, and parkinsonism, may be present during acute

91 nt our approach for evaluating patients with myoclonus, and suggest practical guidelines for treating

92 gressive encephalomyelitis with rigidity and myoclonus, and two as stiff person syndrome; five had a

93 Clinical presentations of myoclonus are divided into physiological, essential, epi

94 ations which are being used in management of myoclonus are levetiracetam and gamma-hydroxybutyric aci

95 Most causes of myoclonus are symptomatic and include posthypoxia, toxic

96 g with definitions and treatment options for myoclonus, are included to guide the clinician.

97 ment disorders (41%), including dystonia and myoclonus as presenting symptoms.

98 determining the medical significance of the myoclonus as well as for its treatment.

99 gressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antib

100 5-phosphonopentanoic acid (AP5, 20 mM) block myoclonus at a latency of 0.6-3 min with the block lasti

101 The severity of action myoclonus at baseline correlated negatively with the con

102 s in their behaviour, facial automatisms and myoclonus at the time of epileptiform ECoG events.

103 em reflexes, motor response, and presence of myoclonus) at Day 3 after cardiac arrest remains an accu

104 rotein Nova-1, the paraneoplastic opsoclonus-myoclonus ataxia (POMA) antigen.

105 Paraneoplastic opsoclonus myoclonus ataxia (POMA) is a neurologic disorder thought

106 toimmune target in paraneoplastic opsoclonus myoclonus ataxia (POMA) patients with latent cancer, red

107 an autoantigen in paraneoplastic opsoclonus myoclonus ataxia (POMA), a disorder associated with brea

108 tigens targeted in paraneoplastic opsoclonus myoclonus ataxia (POMA), an autoimmune neurologic diseas

109 nts suffering from paraneoplastic opsoclonus myoclonus ataxia (POMA), Nova-1 and Nova-2 proteins are

110 utoimmune disorder paraneoplastic opsoclonus-myoclonus ataxia (POMA).

111 gic condition, the paraneoplastic opsoclonus-myoclonus ataxia (POMA).

112 ic motor disorder [paraneoplastic opsoclonus-myoclonus ataxia (POMA)].

113 utoimmune disorder paraneoplastic opsoclonus-myoclonus ataxia and contain K-homology (KH)-type RNA bi

114 ith the possible exception of the opsoclonus-myoclonus ataxia and Lambert-Eaton myasthenic syndromes.

115 utoimmune disorder paraneoplastic opsoclonus-myoclonus ataxia, which is characterized by failure of i

116 l symptoms, termed paraneoplastic opsoclonus-myoclonus ataxia.

117 ruses (n=31) by the neurological findings of myoclonus, ataxia, weakness, and autonomic instability.

118 in the Americas, was characterised by fever, myoclonus, ataxia, weakness, autonomic instability, and

119 he pathogenesis of paraneoplastic opsoclonus-myoclonus-ataxia (POMA).

120 Opsoclonus-myoclonus-ataxia syndrome (OMS) is a severe autoimmune c

121 yotonia (Caspr2 antibodies), and opsoclonus--myoclonus--ataxia (unknown antigens).

122 induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without im

123 For patients with clinically evident myoclonus before awakening, 2 expert physicians reviewed

124 with hyperekplexia or non-epileptic erratic myoclonus being the most prevalent feature (8/25).

125 In five cases, the myoclonus completely resolved within 2 days of onset, wh

126 ric limb rigidity and apraxia with dystonia, myoclonus, cortical sensory loss and alien limb phenomen

127 ental disorder, generalized epilepsy, action myoclonus/cortical tremor and ataxia.

128 (supranuclear vertical gaze palsy, rhythmic myoclonus, dementia with psychiatric symptoms, or hypoth

129 The evaluation of a patient with myoclonus depends completely on the clinical history and

130 confirmed shorter survival in patients with myoclonus (difference, -125.9 [95% CI, -236.3 to -15.5]

131 ents with multifocal high frequency rhythmic myoclonus due to non-progressive conditions.

132 Myoclonus dystonia (DYT11) is a movement disorder caused

133 as recently been shown to be associated with myoclonus dystonia (M-D) in one large family.

134 Myoclonus dystonia (M-D) is a hereditary movement disord

135 Hereditary autosomal dominant myoclonus dystonia (MD) is a movement disorder character

136 Myoclonus dystonia is a childhood-onset hyperkinetic mov

137 We established a cohort of patients with myoclonus dystonia syndrome and SGCE mutations to determ

138 Myoclonus dystonia syndrome is a childhood onset hyperki

139 n all, 89 patients with clinically suspected myoclonus dystonia syndrome were recruited from the UK a

140 SGCE) cause the neurogenic movement disorder myoclonus dystonia syndrome.

141 dystonia, writer's cramp, cranial dystonia, myoclonus dystonia, and off-state dystonia associated wi

142 (DYT6 and DYT13), dopa-responsive dystonia, myoclonus dystonia, rapid-onset dystonia parkinsonism, F

143 romuscular disorders, such as hyperekplexia, myoclonus, dystonia, and epilepsy.

144 Myoclonus-dystonia (M-D) is a clinical syndrome characte

145 DYT11 myoclonus-dystonia (M-D) is a movement disorder characte

146 Myoclonus-dystonia (M-D) is a rare movement disorder cha

147 Myoclonus-dystonia (M-D) is a very rare movement disorde

148 rity of depressive symptoms in patients with myoclonus-dystonia and healthy volunteers (HV).

149 port a large kindred with essential familial myoclonus-dystonia and map a locus for the disorder to a

150 rophysiological subcortical abnormalities in myoclonus-dystonia and their modulation by alcohol admin

151 Essential myoclonus-dystonia is a neurological condition character

152 Myoclonus-dystonia is a rare and homogeneous neurodevelo

153 Myoclonus-dystonia patients also shared some common path

154 rainstem interaction were investigated in 17 myoclonus-dystonia patients with epsilon-sarcoglycan (SG

155 generated iPSC-derived cortical neurons from myoclonus-dystonia patients with mutations (W100G and R1

156 ved cortical neurons with SGCE mutations for myoclonus-dystonia research and, in more general terms,

157 Myoclonus-dystonia syndrome (MDS) is a genetically heter

158 Myoclonus-dystonia with a proven SGCE mutation.

159 solated dystonia, good treatment response in myoclonus-dystonia, and suggest that early treatment cor

160 Clinical and genetic heterogeneity underlie myoclonus-dystonia, dopa-responsive dystonia and deafnes

161 erexcitability characteristic of this unique myoclonus-dystonia-like syndrome associated with cardiac

162 ree-generation family with a unique dominant myoclonus-dystonia-like syndrome with cardiac arrhythmia

163 so described in autism spectrum disorder and myoclonus-dystonia.

164 nResponsiveness [FOUR] score at 72 hr, early myoclonus), electroencephalography (EEG) (reactivity, co

165 clinical examination (brainstem reflexes and myoclonus), electroencephalography reactivity during the

166 Progressive myoclonus epilepsies (PMEs) are a group of rare, inherit

167 Progressive myoclonus epilepsies (PMEs) comprise a group of clinical

168 el for human Unverricht-Lundborg progressive myoclonus epilepsy (EPM1) on 21q22.3 nor for spinocerebe

169 ations in EPM2A or EPM2B a fatal progressive myoclonus epilepsy (Lafora disease).

170 ickle 1 (Pk1) is associated with progressive myoclonus epilepsy (PME) in humans, and its reduced gene

171 Progressive myoclonus epilepsy (PME) is a syndrome characterized by

172 gregating an autosomal recessive progressive myoclonus epilepsy (PME) with early ataxia.

173 comprehensively describe the new syndrome of myoclonus epilepsy and ataxia due to potassium channel m

174 nerative disease that results in progressive myoclonus epilepsy and death.

175 n this study CNS tissues from a patient with myoclonus epilepsy and ragged red fibers (MERRF) syndrom

176 Lafora disease is a progressive myoclonus epilepsy caused by mutations in the EPM2A or E

177 disease (LD) is a fatal form of progressive myoclonus epilepsy caused by recessive mutations in eith

178 Lafora disease is a fatal, progressive myoclonus epilepsy caused in ~90% of cases by mutations

179 fora disease is a rare and fatal progressive myoclonus epilepsy characterized by the accumulation of

180 LD) is a teenage-onset inherited progressive myoclonus epilepsy characterized by the accumulations of

181 is an autosomal recessive, fatal progressive myoclonus epilepsy characterized by the intracellular bu

182 Lafora disease (LD) is a fatal progressive myoclonus epilepsy characterized neuropathologically by

183 CBD of laforin likely result in progressive myoclonus epilepsy due to mis-localization of phosphatas

184 5, we mapped a gene for Lafora's progressive myoclonus epilepsy in chromosome 6q23-25.

185 Lafora disease (progressive myoclonus epilepsy of Lafora type) is an autosomal reces

186 The gene responsible for progressive myoclonus epilepsy of the Unverricht-Lundborg type (EPM1

187 Progressive myoclonus epilepsy of the Unverricht-Lundborg type (EPM1

188 with several features akin to of progressive myoclonus epilepsy such as neuronal ceroid lipofuscinosi

189 ene ( CSTB ) are responsible for progressive myoclonus epilepsy type 1 (EPM1; MIM 254800).

190 The typical presentation was of progressive myoclonus epilepsy with debilitating myoclonic seizures

191 in, leading to neurodegeneration in mice and myoclonus epilepsy with dementia in humans.

192 Lafora disease is a progressive myoclonus epilepsy with onset in the teenage years follo

193 afora disease (LD) is an autosomal recessive myoclonus epilepsy with onset in the teenage years leadi

194 Lafora disease is a progressive myoclonus epilepsy with onset typically in the second de

195 cidosis and stroke-like episodes (MELAS) and myoclonus epilepsy with ragged-red fibers (MERRF).

196 Clinical distinction of type A (progressive myoclonus epilepsy) and type B (dementia with motor dist

197 on but may also be seen in Lafora's disease (myoclonus epilepsy), cyanamide alcohol aversion therapy,

198 a disease, a fatal teenage-onset progressive myoclonus epilepsy, are caused by mutations in either th

199 E) resulted, at age 13 years, in progressive myoclonus epilepsy, with many inclusions present in almo

200 ata sets for cystic fibrosis and progressive myoclonus epilepsy.

201 disease, Friedreich ataxia, and progressive myoclonus epilepsy.

202 Lafora disease is a fatal progressive myoclonus epilepsy.

203 6OS are a novel genetic cause of progressive myoclonus epilepsy.

204 med in 2 unrelated families with progressive myoclonus epilepsy.

205 aluated for target symptoms (hallucinations, myoclonus, fatigue, and sedation), global well-being, an

206 ation, clumsy useless limb, limb apraxia and myoclonus, four had cortical sensory impairment and foca

207 presented with cerebellar ataxia and severe myoclonus from adolescence.

208 Patients with myoclonus had longer time to professional cardiopulmonar

209 cal analysis showed that the cats generating myoclonus hemorrhagic lesions in the retrorubral nucleus

210 enotype that includes severe infantile onset myoclonus, hypotonia, optic nerve abnormalities, dysphag

211 nus and is part of the 'spectrum of cortical myoclonus', i.e. a wide range of clinical motor phenomen

212 Myoclonus improved significantly after alcohol intake (p

213 play a significant role in the generation of myoclonus in a rat model of posthypoxic myoclonus.

214 ce (PVG) in post-hypoxic rats that developed myoclonus in response to auditory stimuli.

215 with encephalopathy and developed prolonged myoclonus in the absence of clear systemic provoking fac

216 VG significantly reduced auditory stimulated myoclonus in the post-hypoxic rats.

217 tor antagonists would exacerbate posthypoxic myoclonus in this animal model.

218 sessment of patients with suspected cortical myoclonus in whom myoclonic EMG bursts repeat rhythmical

219 spiratory failure (fatal in 1 case), startle myoclonus (in 2 unrelated cases), axial rigidity, and Pa

220 The assessment of myoclonus includes an initial screening for those causes

221 Myoclonus is a far less common problem.

222 Post-hypoxic myoclonus is a movement disorder characterized by brief,

223 PRETATION: We propose that familial cortical myoclonus is a novel movement disorder that may be cause

224 gressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle s

225 Myoclonus is characterized by sudden, brief involuntary

226 Cortical myoclonus is produced by abnormal neuronal discharges wi

227 Although myoclonus less than or equal to 72 hours after cardiac a

228 l discharge was noted in 9% of patients with myoclonus, less frequently in myoclonus with epileptifor

229 episodes), dryness of mouth (two episodes), myoclonus like activity of eyelids (four episodes), ocul

230 ve, motor, and sensory examinations, tremor, myoclonus, local sensory symptoms, symptoms at the expos

231 cohorts to determine whether the presence of myoclonus may aid in the assessment of disease severity,

232 The sudden, shock-like jerks which define myoclonus may be highly disabling, and when they persist

233 Our findings suggest that myoclonus may be observed in severe acute respiratory sy

234 Data on patients presenting myoclonus, MyS/SM, MSE, and eLAS less than or equal to 7

235 gressive encephalomyelitis with rigidity and myoclonus (n = 1).

236 (n = 14), or extrapyramidal (n = 12) signs, myoclonus (n = 12), visual disturbance (n = 9), and akin

237 The remaining patients had subcortical myoclonus (n = 2, 3%) or other patterns (n = 7, 11%).

238 mes (transverse myelitis [n = 1], opsoclonus myoclonus [n = 1]).

239 y of the movement disorders was complex with myoclonus observed in 68.3% of cases (28/41), either in

240 signs was decreased, and the development of myoclonus occurred later among patients with APOE epsilo

241 ld a higher percentage of good outcomes, but myoclonus of itself should not be considered a sign of f

242 Paroxysmal orthostatic segmental myoclonus of the legs is a novel albeit rare manifestati

243 Ten patients affected by cortical myoclonus of various aetiology and 10 aged-matched healt

244 bstrate of the clinical manifestations (i.e. myoclonus) of the photoparoxysmal response.

245 pite circumstantial evidence that opsoclonus-myoclonus (OM) is often immune mediated, no specific aut

246 Myoclonus, one of the most common involuntary movement d

247 gressive encephalomyelitis with rigidity and myoclonus or stiff person syndrome, and glycine receptor

248 re brainstem syndrome (including opsoclonus, myoclonus, or both), cerebellar syndrome, myelopathy, pe

249 No patients with Pattern 1, subcortical myoclonus, or other patterns survived with favorable out

250 althy participants had excessive fragmentary myoclonus (p=0.039), and nine (38%) patients, but no hea

251 G) phenotypes of early postanoxic multifocal myoclonus (PAMM) that develop after cardiac arrest.

252 the processes underlying different types of myoclonus, particularly cortical forms.

253 Myoclonus presents as a sudden brief jerk caused by invo

254 g Delirium Screening Scale (NuDESC), Unified Myoclonus Rating Scale (UMRS), Functional Assessment of

255 evaluation of patients included the Unified Myoclonus Rating Scale and Burke-Fahn-Marsden Dystonia R

256 clinical rating scales including the Unified Myoclonus Rating Scale and the Burke-Fahn-Marsden Dyston

257 Myoclonus remains the commonest movement disorder associ

258 Variants in the LIMP-2 gene cause action myoclonus-renal failure syndrome and also have been link

259 Myoclonus, rigidity and hallucinations were more frequen

260 The myoclonus scores for the posthypoxic rats treated with m

261 e sum of four dehydration symptoms (fatigue, myoclonus, sedation and hallucinations, 0 = best and 40

262 ra bodies and rescues the neurodegeneration, myoclonus, seizure susceptibility, and behavioral abnorm

263 ear gaze palsy, hypothalamic manifestations, myoclonus, seizures, ataxia, or OMM, especially when tis

264 ive or behavioural symptoms, and presence of myoclonus, seizures, pyramidal signs, extrapyramidal sig

265 sented with subacute cerebellar syndrome and myoclonus several days after general infectious symptoms

266 es such as limbic encephalitis or opsoclonus-myoclonus should always raise suspicion of a paraneoplas

267 The motor cortex is the most commonly shown myoclonus source, but origins from subcortical areas, br

268 rating the distinct elements of the cortical myoclonus spectrum, and how cortical tremor fits into it

269 horea, ballism, athetosis, dystonia, tremor, myoclonus, stereotypies, and akathisia.

270 ers include tremors, dystonia, chorea, tics, myoclonus, stereotypies, restless legs syndrome, and var

271 rvations establish the etiology of sustained myoclonus (sudden involuntary muscle movements) and earl

272 A neurophysiological study of the myoclonus suggested a cortical origin.

273 Most studies on opsoclonus-myoclonus syndrome (OMS) in adults are based on small ca

274 ic cerebellar degeneration, and 1 opsoclonus-myoclonus syndrome).

275 2 patients recovering from viral opsoclonus-myoclonus syndrome, comparing saccadic-vergence response

276 ingoencephalomyelitis, and 1 with opsoclonus myoclonus syndrome.

277 sensorimotor cortex excitability in cortical myoclonus syndromes.

278 t for Parkinson tremor and rhythmic cortical myoclonus, the discovery of drugs for tremor disorders h

279 nge of clinical motor phenomena, from reflex myoclonus to myoclonic epilepsy, caused by abnormal sens

280 mands only and abnormal movements, including myoclonus, tongue and orofacial dyskinesias, and opsoclo

281 inherited disorders manifesting with action myoclonus, tonic-clonic seizures and ataxia.

282 CLN8 disease patients present with myoclonus, tonic-clonic seizures, and progressive declin

283 bability including seizures, encephalopathy, myoclonus, tremor and spasticity, with immunotherapy res

284 Myoclonus, tremor, and ethanol hypersensitivity are only

285 Symptoms included agitation, confusion, myoclonus, tremor, and seizures (1 case with prominent s

286 nervous system hyperexcitability (agitation, myoclonus, tremor, seizures), pleocytosis, and frequent

287 Epilepsy of progressive myoclonus type 2 gene A (EPM2A) encodes a dual specifici

288 large, 4-generation family with a history of myoclonus underwent careful questioning, examination, an

289 In patients, myoclonus was recorded by the means of surface EMG befor

290 Among 3881 patients, myoclonus was reported in 2659, MyS/SM in 883, MSE in 56

291 bnormal nuclear envelopes, motor deficits or myoclonus, we produced paternally inherited striatum-spe

292 Outcomes in patients with myoclonus were variable, with one patient who died durin

293 tient had severe axial and limb rigidity and myoclonus, which partially improved after chemotherapy a

294 Fifteen patients with eyelid myoclonus with absences (EMA, Jeavons syndrome), 14 pati

295 num toxin is also being introduced for focal myoclonus with encouraging results.

296 patients with myoclonus, less frequently in myoclonus with epileptiform activity (2% vs 15%; p < 0.0

297 Electroencephalography demonstrated myoclonus with epileptiform activity in 209 of 374 (55%)

298 Patients with myoclonus with good outcome were younger (53.7 vs 62.7 y

299 family suffering from adult onset, cortical myoclonus without associated seizures.

300 eizures that were initially considered to be myoclonus without cognitive decline.